Sivan Izraely

Sivan Izraely

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

The S1P/S1P1 Signaling Axis Plays Regulatory Functions in the Crosstalk Between Brain-Metastasizing Melanoma Cells and Microglia.

The S1P/S1P1 Signaling Axis Plays Regulatory Functions in the Crosstalk Between Brain-Metastasizing Melanoma Cells and Microglia.

Journal: Cancers
Published: June 10, 2025

A heterodimer of hemoglobin identifies theranostic targets on brain-metastasizing melanoma cells.

A heterodimer of hemoglobin identifies theranostic targets on brain-metastasizing melanoma cells.

Journal: International journal of cancer
Published: October 28, 2024

Melanoma Cells from Different Patients Differ in Their Sensitivity to Alpha Radiation-Mediated Killing, Sensitivity Which Correlates with Cell Nuclei Area and Double Strand Breaks.

Melanoma Cells from Different Patients Differ in Their Sensitivity to Alpha Radiation-Mediated Killing, Sensitivity Which Correlates with Cell Nuclei Area and Double Strand Breaks.

Journal: Cancers
Published: October 15, 2024

Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression.

Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression.

Journal: Cancers
Published: August 08, 2023

The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway.

The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway.

Journal: Cells
Published: March 28, 2023

A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent.

A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent.

Journal: International journal of cancer
Published: February 01, 2023

Cancer microenvironment and genomics: evolution in process.

Cancer microenvironment and genomics: evolution in process.

Journal: Clinical & experimental metastasis
Published: April 06, 2021

Cancer drug resistance induced by EMT: novel therapeutic strategies.

Cancer drug resistance induced by EMT: novel therapeutic strategies.

Journal: Archives of toxicology
Published: March 05, 2021

The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.

The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.

Journal: Molecular oncology
Published: September 30, 2020

Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation.

Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation.

Journal: Cells
Published: July 01, 2020

Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.

Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.

Journal: International journal of cancer
Published: March 29, 2020

Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.

Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.

Journal: Molecular oncology
Published: January 09, 2020
Showing 1-12 of 24

Last Updated: 09/26/2026